sees fy adjusted earnings per share $7.50 to $765.
sees fy adjusted earnings per share $7.40 to $7,60.
q3 adjusted earnings per share $1.72.
sees 2021 net sales growth of 2% to 3%.
sees fy organic sales growth of 5% to 5%.
sees 2021 revenue growth of 9% to 11% year-on-year.
sees q4 organic sales up about 6%.
q3 sales $4.7 billion.
sees fy sales about $2.15 billion.
qtrly organic sales increased 3%.
q4 adjusted operating profit fell 6 percent to $1.2 billion.
qtrly k-c professional margins were down significantly, including an approximate 600 basis point drag from fixed costs under absorption.
qtrly organic sales rose 10% in consumer tissue and 5% in personal care, but declined 15% in k-c professional.
q3 cash provided by operations $559 million versus $886 million.
q3 adjusted gross margin was 36.2%.
compname reports q3 earnings per share of $0.51.
